metaraminol has been researched along with meperidine in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (66.67) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Shubin, H; Weil, MH | 1 |
AGRESS, CM | 1 |
2 review(s) available for metaraminol and meperidine
Article | Year |
---|---|
Practical considerations in the management of shock complicating acute myocardial infarction. A summary of current practice.
Topics: Acute Disease; Arrhythmias, Cardiac; Atropine; Blood Pressure Determination; Central Venous Pressure; Digitalis Glycosides; Electrocardiography; Heart Failure; Humans; Hydromorphone; Infusions, Parenteral; Isoproterenol; Lidocaine; Meperidine; Metaraminol; Monitoring, Physiologic; Morphine; Myocardial Infarction; Norepinephrine; Oxygen Inhalation Therapy; Shock, Cardiogenic | 1970 |
THERAPY OF CARDIOGENIC SHOCK.
Topics: Angiotensins; Cardiac Tamponade; Heart Aneurysm; Heart Diseases; Heart Failure; Humans; Hydromorphone; Meperidine; Mephentermine; Metaraminol; Methoxamine; Morphine; Myocarditis; Norepinephrine; Oxygen; Pericarditis; Phentolamine; Phenylephrine; Pulmonary Heart Disease; Shock; Shock, Cardiogenic | 1963 |
1 other study(ies) available for metaraminol and meperidine
Article | Year |
---|---|
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |